Tag: TSC

Novartis’ Afinitor Disperz wins new TSC-related approval

by Selina McKee | Apr 11, 2018 | News | 0

Novartis’ Afinitor Disperz has become the first medicine to be specifically approved by US regulators to treat patients aged two years and above with tuberous sclerosis complex (TSC)-associated partial-onset seizures.

EC further expands use of Novartis’ Votubia

by Selina McKee | Jan 31, 2017 | News | 0

The European Commission has expanded the approved uses of Novartis’ Votubia to include adjunctive treatment of patients aged two years and older whose refractory partial-onset seizures, with or without secondary generalisation, are associated with tuberous sclerosis complex.